UBS Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Sell |
227,600
-36,317
| -14% | -$32.9K | ﹤0.01% | 5462 |
|
|
2025
Q1 | $119K | Buy |
263,917
+43,029
| +19% | +$19.4K | ﹤0.01% | 5646 |
|
|
2024
Q4 | $111K | Buy |
220,888
+49,457
| +29% | +$24.8K | ﹤0.01% | 5591 |
|
|
2024
Q3 | $155K | Buy |
171,431
+94,965
| +124% | +$85.9K | ﹤0.01% | 4873 |
|
|
2024
Q2 | $76.2K | Sell |
76,466
-63,606
| -45% | -$63.4K | ﹤0.01% | 5222 |
|
|
2024
Q1 | $207K | Sell |
140,072
-4,455
| -3% | -$6.59K | ﹤0.01% | 4690 |
|
|
2023
Q4 | $158K | Buy |
144,527
+91,556
| +173% | +$99.8K | ﹤0.01% | 4733 |
|
|
2023
Q3 | $62.5K | Sell |
52,971
-8,066
| -13% | -$9.52K | ﹤0.01% | 5032 |
|
|
2023
Q2 | $86.1K | Buy |
61,037
+57,784
| +1,776% | +$81.5K | ﹤0.01% | 5080 |
|
|
2023
Q1 | $4.88K | Sell |
3,253
-7,253
| -69% | -$10.9K | ﹤0.01% | 7030 |
|
|
2022
Q4 | $12.3K | Buy |
10,506
+9,204
| +707% | +$10.8K | ﹤0.01% | 7101 |
|
|
2022
Q3 | $1K | Sell |
1,302
-10,118
| -89% | -$7.77K | ﹤0.01% | 8870 |
|
|
2022
Q2 | $18K | Buy |
11,420
+10,526
| +1,177% | +$16.6K | ﹤0.01% | 5979 |
|
|
2022
Q1 | $1K | Sell |
894
-39,038
| -98% | -$43.7K | ﹤0.01% | 8825 |
|
|
2021
Q4 | $97K | Sell |
39,932
-167,770
| -81% | -$408K | ﹤0.01% | 5268 |
|
|
2021
Q3 | $523K | Buy |
207,702
+203,156
| +4,469% | +$512K | ﹤0.01% | 3705 |
|
|
2021
Q2 | $13K | Sell |
4,546
-2,791
| -38% | -$7.98K | ﹤0.01% | 6687 |
|
|
2021
Q1 | $17K | Sell |
7,337
-17,265
| -70% | -$40K | ﹤0.01% | 6495 |
|
|
2020
Q4 | $44K | Buy |
24,602
+23,483
| +2,099% | +$42K | ﹤0.01% | 5302 |
|
|
2020
Q3 | $1K | Sell |
1,119
-238
| -18% | -$213 | ﹤0.01% | 6911 |
|
|
2020
Q2 | $1K | Sell |
1,357
-69,559
| -98% | -$51.3K | ﹤0.01% | 6910 |
|
|
2020
Q1 | $59K | Sell |
70,916
-84,997
| -55% | -$70.7K | ﹤0.01% | 4812 |
|
|
2019
Q4 | $139K | Buy |
155,913
+72,340
| +87% | +$64.5K | ﹤0.01% | 4809 |
|
|
2019
Q3 | $82K | Buy |
83,573
+59,781
| +251% | +$58.7K | ﹤0.01% | 4955 |
|
|
2019
Q2 | $26K | Buy |
23,792
+11,894
| +100% | +$13K | ﹤0.01% | 5569 |
|
|
2019
Q1 | $15K | Sell |
11,898
-42,804
| -78% | -$54K | ﹤0.01% | 5707 |
|
|
2018
Q4 | $49K | Sell |
54,702
-24,348
| -31% | -$21.8K | ﹤0.01% | 5206 |
|
|
2018
Q3 | $162K | Buy |
79,050
+47,046
| +147% | +$96.4K | ﹤0.01% | 4375 |
|
|
2018
Q2 | $58K | Buy |
32,004
+14,859
| +87% | +$26.9K | ﹤0.01% | 4971 |
|
|
2018
Q1 | $40K | Buy |
17,145
+7,502
| +78% | +$17.5K | ﹤0.01% | 5027 |
|
|
2017
Q4 | $18K | Buy |
9,643
+9,243
| +2,311% | +$17.3K | ﹤0.01% | 5660 |
|
|
2017
Q3 | $1K | Sell |
400
-481
| -55% | -$1.2K | ﹤0.01% | 6647 |
|
|
2017
Q2 | $2K | Buy |
881
+481
| +120% | +$1.09K | ﹤0.01% | 6425 |
|
|
2017
Q1 | $1K | Sell |
400
-8,382
| -95% | -$21K | ﹤0.01% | 6493 |
|
|
2016
Q4 | $27K | Buy |
8,782
+6,808
| +345% | +$20.9K | ﹤0.01% | 5377 |
|
|
2016
Q3 | $7K | Buy |
1,974
+25
| +1% | +$89 | ﹤0.01% | 6054 |
|
|
2016
Q2 | $4K | Sell |
1,949
-960
| -33% | -$1.97K | ﹤0.01% | 6321 |
|
|
2016
Q1 | $7K | Sell |
2,909
-2,653
| -48% | -$6.38K | ﹤0.01% | 5999 |
|
|
2015
Q4 | $18K | Buy |
5,562
+2,409
| +76% | +$7.8K | ﹤0.01% | 5643 |
|
|
2015
Q3 | $8K | Buy |
3,153
+1,349
| +75% | +$3.42K | ﹤0.01% | 6040 |
|
|
2015
Q2 | $6K | Sell |
1,804
-1,349
| -43% | -$4.49K | ﹤0.01% | 6217 |
|
|
2015
Q1 | $13K | Sell |
3,153
-3,328
| -51% | -$13.7K | ﹤0.01% | 5707 |
|
|
2014
Q4 | $19K | Buy |
+6,481
| New | +$19K | ﹤0.01% | 5596 |
|